Stanford chemists uncover new pathway for protein degradation, opening door to new therapeutics

When targeting problem proteins involved in causing or spreading disease, a drug will often clog up a protein’s active site so it can’t function and wreak havoc.

Risk Adjusted Net Present Value: What is the current valuation of AstraZeneca’s Rilvegostomig

The revenue for Rilvegostomig is expected to reach an annual total of $103 mn by 2039 in the US based off GlobalData’s Expiry Model. The

July 2, 2024

Amicus stock jumps after resolution of Galafold patent litigation against Teva

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

October 18, 2024

Rad AI and Google Join Forces to Revolutionize Radiology Reporting with AI

What You Should Know: – Rad AI, an AI startup revolutionizing radiology reporting is teaming up with Google to tackle radiologists’ workload and elevate patient

January 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.